COMP <GO>
DCTH vs LLY // GROSS PROFIT MARGIN
Delcath Systems Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: DCTH 4
— LLY 7
▲ GROSS PROFIT MARGIN LEADER: DCTH
LAST: $14.64 (-1.48%) • MKT CAP: $508.0M
gross-margins
86.20%
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
gross-margins
83.64%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCTH | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 86.20% | 83.64% | +2.56 | DCTH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | 32.36% | -31.56 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.13% | 2.30% | +1.83 | DCTH | /fcf-yield <GO> |
| Operating Margin | 0.80% | 40.21% | -39.41 | LLY | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 31.90% | -28.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 129.10% | 45.51% | +83.59 | DCTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 20.33 | 9.29 | +11.04 | DCTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 66.6 | -29.32 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 26.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $508.0M | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCTH REV | LLY REV | DCTH GROSS % | LLY GROSS % | DCTH FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $85.2M | $65.18B | 86.2% | 83.0% | $21.0M | $16.81B |
| FY 2024 | $37.2M | $45.04B | 83.4% | 81.3% | -$19.2M | $8.82B |
| FY 2023 | $2.1M | $34.12B | — | 79.3% | -$31.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
LLY // BETA 0.51